Conception antisens

• 收藏
• 分享

专利权人:

ROCHE INNOVATION CENTER COPENHAGEN A/S

发明人:

申请号：

EP09169370.5

公开号：

EP2141233B1

申请日:

2003.11.18

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

A class of pharmaceuticals which comprises a Locked Nucleic Acid (LNA) which can be used in antisense therapy. These oligonucleotides have improved antisense properties. The oligonucleotides are composed of at least one LNA selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA. The oligonucleotides comprising LNA may also include DNA and/or RNA nucleotides.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/